Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tonkin

Showing results (261-270 of 338) with videos related to

Pageof 34
Sort By:
Nephrology (Carlton, Vic.)|November 11, 2014
The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility StudyMatthew A Roberts, Helen L Pilmore, Francesco L Ierino, et al.
Molecular Cell|September 5, 2006
Mycobacteriophage exploit NHEJ to facilitate genome circularizationRobert S Pitcher, Louise M Tonkin, James M Daley, et al.
Circulation. Genomic and Precision Medicine|June 12, 2020
Familial Hypercholesterolemia in a Healthy Elderly PopulationPaul Lacaze, Robert Sebra, Moeen Riaz, et al.
The Medical Journal of Australia|December 16, 2014
An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trialTracey-Lea Laba, Alison Hayes, Serigne Lo, et al.
Circulation|January 26, 2018
D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID StudyJohn Simes, Kristy P Robledo, Harvey D White, et al.
Lancet (London, England)|October 9, 2018
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trialsPeter Willeit, Paul M Ridker, Paul J Nestel, et al.
Annals of Internal Medicine|March 14, 2022
Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized TrialMark R Nelson, Galina Polekhina, Robyn L Woods, et al.
Circulation|June 20, 2007
Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)Elizabeth L M Barr, Paul Z Zimmet, Timothy A Welborn, et al.
Plos One|February 29, 2024
The ASPREE Healthy Ageing Biobank: Methodology and participant characteristicsEmily J Parker, Suzanne G Orchard, Tom J Gilbert, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 1, 2023
Cognitive trajectories and incident dementia after a cardiovascular event in older adultsSwarna Vishwanath, Ingrid Hopper, Rory Wolfe, et al.
Pageof 34

Showing results (261-270 of 338) with videos related to

Sort By:
Pageof 34
Nephrology (Carlton, Vic.)|November 11, 2014
The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility StudyMatthew A Roberts, Helen L Pilmore, Francesco L Ierino, et al.
Molecular Cell|September 5, 2006
Mycobacteriophage exploit NHEJ to facilitate genome circularizationRobert S Pitcher, Louise M Tonkin, James M Daley, et al.
Circulation. Genomic and Precision Medicine|June 12, 2020
Familial Hypercholesterolemia in a Healthy Elderly PopulationPaul Lacaze, Robert Sebra, Moeen Riaz, et al.
The Medical Journal of Australia|December 16, 2014
An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trialTracey-Lea Laba, Alison Hayes, Serigne Lo, et al.
Circulation|January 26, 2018
D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID StudyJohn Simes, Kristy P Robledo, Harvey D White, et al.
Lancet (London, England)|October 9, 2018
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trialsPeter Willeit, Paul M Ridker, Paul J Nestel, et al.
Annals of Internal Medicine|March 14, 2022
Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized TrialMark R Nelson, Galina Polekhina, Robyn L Woods, et al.
Circulation|June 20, 2007
Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)Elizabeth L M Barr, Paul Z Zimmet, Timothy A Welborn, et al.
Plos One|February 29, 2024
The ASPREE Healthy Ageing Biobank: Methodology and participant characteristicsEmily J Parker, Suzanne G Orchard, Tom J Gilbert, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 1, 2023
Cognitive trajectories and incident dementia after a cardiovascular event in older adultsSwarna Vishwanath, Ingrid Hopper, Rory Wolfe, et al.
Pageof 34